GO
Loading...

The Flaws in Emerging Market Strategy

Tuesday, 2 Apr 2013 | 11:35 AM ET

Andrew Weiss, head of pharma and biotech research at Vontobel, tells CNBC why Novartis' failure to win its battle for patent protection for the drug Glivec highlights the flaws in pharma companies' emerging market strategy.